Prize contingency management for smoking cessation: A randomized trial

Drug and Alcohol Dependence

Volumn 140, Issue , 2014, Pages 208-212

  Ledgerwood, David M ^a   Arfken, Cynthia L ^a   Petry, Nancy M ^b   Alessi, Sheila M ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Cigarette; Contingency management; Prize; Tobacco; Treatment efficacy

Indexed keywords

BUPRENORPHINE PLUS NALOXONE; DIAMORPHINE; CARBON MONOXIDE; COTININE;

ABSTINENCE; ADDICTION SEVERITY INDEX; ADULT; ARTICLE; CHRONIC PAIN; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG ABUSE PATTERN; EXPOSURE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MULTICENTER STUDY (TOPIC); OPIATE ADDICTION; PATIENT COMPLIANCE; PATIENT COUNSELING; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCORING SYSTEM; TREATMENT OUTCOME; BEHAVIOR THERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; METABOLISM; MIDDLE AGED; PROCEDURES; PSYCHOLOGY; REINFORCEMENT; REWARD; SMOKING CESSATION; SOCIOECONOMICS; TOBACCO USE DISORDER; URINE;

NICOTIANA TABACUM;

ADULT; BEHAVIOR THERAPY; CARBON MONOXIDE; COTININE; FEMALE; HUMANS; MALE; MIDDLE AGED; REINFORCEMENT SCHEDULE; REWARD; SMOKING CESSATION; SOCIOECONOMIC FACTORS; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 84924837168     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2014.03.032     Document Type: Article

References (21)

1. Alessi S.M., Petry N.M., Urso J. Contingency management promotes smoking reductions in residential substance abuse patients. J. Appl. Behav. Anal. 2008, 41:617-622.
2. Centers for Disease Control and Prevention Smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 2000-2004. MMWR 2008, 57:1226-1228.
3. Corby E.A., Roll J.M., Ledgerwood D.M., Schuster C.R. Contingency management interventions for treating the substance abuse of adolescents: a feasibility study. Exp. Clin. Psychopharmacol. 2000, 8:371-376.
4. Dutra L., Stathopoulou G., Basden S.L., Leyro T.M., Powers M.B., Otto M.W. A meta-analytic review of psycosocial interventions for substance use disorders. Am. J. Psychiatry 2008, 165:179-187.
5. Fagerstrom K.-O. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict. Behav. 1978, 3:235-241.
6. First M.B., Gibbon M., Spitzer R.L., Williams J.B.W. The Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P). Biometrics Research 2002, New York State Psychiatric Institute, New York, NY.
7. Fiore M.C., Jaen C.R., Baker T.B., Bailey W.C., Benowitz N.L., Curry S.J., Dorfman S.F., Froelicher E.S., Goldstein M.G., Healton C.G., Nez Henderson P., Heyman R.B., et al. Treating Tobacco Use and Dependence: 2008 Update. U.S. Department of Health and Human Services 2008, Public Health Service, Rockville, MD.
8. Gerstein D., Murphy S., Toce M., Hoffmann J., Palmer A., Johnson R., et al. Gambling Impact and Behavior Study 1999, University of Chicago, Chicago.
9. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerstrom K.O. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br. J. Addict. 1991, 86:1119-1127.
10. Higgins S.T., Heil S.H., Dumeer A.M., Thomas C.S., Solomon L.J., Bernstein I.M. Smoking status in the initial weeks of quitting as a predictor of smoking-cessation outcomes in pregnant women. Drug Alcohol Depend. 2006, 85:138-141.
11. Higgins S.T., Heil S.H., Solomon L.J., Bernstein I.M., Lussieur J.P., Abel R.L., Lynch E., Badger G.J. A pilot study on voucher-based incentives to promote abstinence from cigarette smoking during pregnancy and postpartum. Nicotine Tob. Res. 2004, 6:1015-1020.
12. Kenford S.L., Fiore M.C., Jorenby D.E., Smith S.S., Wetter D., Baker T.B. Predicting smoking cessation. Who will quit with and without the nicotine patch. JAMA 1994, 271:589-594.
13. Lamb R.J., Morral A.R., Kirby K.C., Iguchi M.Y., Galbicka G. Shaping smoking cessation using percentile schedules. Drug Alcohol Depend. 2004, 76:247-259.
14. Ledgerwood D.M. Contingency management for smoking cessation: where do we go from here?. Curr. Drug Abuse Rev. 2008, 1:340-349.
15. Petry N.M., Alessi S.M., Ledgerwood D.M. A randomized trial of contingency management delivered by community therapists. J. Consult. Clin. Psychol. 2012, 80:286-298.
16. Petry N.M., Martin B. Low-cost contingency management for treating cocaine- and opioid-abusing methadone patients. J. Consult. Clin. Psychol. 2002, 70:398-405.
17. Petry N.M., Martin B., Cooney J.L., Kranzler H.R. Give them prizes and they will come: contingency management for treatment of alcohol dependence. J. Consult. Clin. Psychol. 2000, 68:250-257.
18. Petry N.M., Tedford J., Austin M., Nich C., Carroll K.M., Rounsaville B.J. Prize reinforcement contingency management for treating cocaine abusers: how low can we go, and with whom?. Addiction 2004, 99:349-360.
19. Piasecki T.M., Fiore M.C., McCarthy D.E., Baker T.B. Have we lost our way? The need for dynamic formulations of smoking relapse proneness. Addiction 2002, 97:1093-1108.
20. Prendergast M., Podus D., Finney J., Greenwell L., Roll J.M. Contingency management for treatment of substance use disorders: a meta-analysis. Addiction 2006, 101:1546-1560.
21. Silverman K., Wong C.J., Umbricht-Schneiter A., Montoya I.D., Schuster C.R., Preston K.L. Broad beneficial effects of cocaine abstinence reinforcement among methadone patients. J. Consult. Clin. Psychol. 1998, 66:811-824.